Colgate-Palmolive Company

(New York Stock Exchange)
Back to all articles
Somewhat Bearish -25

Is This Safe-Haven Stock Overvalued? The Hidden Risk Facing Colgate-Palmolive on Oct. 30

Earnings report AI-generated analysis

📉 CL stock has surged 21.87% year-to-date but trades at ~24x 2026 EPS, a demanding multiple for a company guiding just 1% to 4% organic growth.

🇺🇸 North America net sales fell 3.0% for the fourth straight quarter as volume dropped 3.9% due to retailer inventory cuts and lost market share.

🛢️ Oil prices climbed to $107.89 per barrel, significantly above management's $90 reference price, threatening back-half margins with zero upward EPS revisions in the last 30 days.

💰 Colgate posted Base Business EPS of $0.99 beating consensus on revenue of $5.36B (+4.9% YoY) driven by pricing power rather than volume growth.

📉 Gross margin expanded 140 bps to 61.5% even as advertising expenses rose 15% to $777M, highlighting the reliance on price increases.

⚠️ Management warned that fixing North American issues will not be linear and expects a volume-driven second half after pricing carried the first half.

📉 Analysts have reduced their outlook with three downward revisions to FY2026 EPS consensus estimates and zero upward revisions over the past month.

🌎 The company does not expect the same Latin American FX benefit it previously relied upon, adding pressure to global growth targets.

🦷 Colgate maintains a 41.3% global toothpaste share and has increased its dividend for 63 consecutive years, supporting its 'safe-haven' investor appeal.

📅 The upcoming Q3 earnings report on Oct. 30 will be critical to validate the stock's premium valuation against rising oil costs and U.S. market contraction.

Bullish Signals
  • Colgate-Palmolive beat EPS estimates for six consecutive quarters with Base Business EPS of $0.99 versus a $0.95 consensus.
  • The company achieved revenue growth of 4.9% year-over-year to $5.36B, demonstrating pricing power in a challenging environment.
  • Gross margin expanded by 140 basis points to 61.5%, indicating effective cost management despite rising advertising spend.
  • The stock holds a premium valuation at ~24x forward earnings, reflecting its status as a defensive safe-haven asset with 63 consecutive years of dividend increases.
  • Colgate maintains a dominant 41.3% global market share in the toothpaste category, providing a strong competitive moat.
Risk Factors
  • North America net sales have declined by 3.0% for four consecutive quarters due to volume contraction and retailer inventory cuts.
  • Oil prices surged to $107.89 per barrel, well above management's $90 reference price, creating significant margin pressure for the back half of the year.
  • Analyst sentiment has deteriorated with three downward revisions to FY2026 EPS consensus estimates and zero upward revisions in the last 30 days.
  • The company faces a volume drag from private label exits in the U.S. pet category, estimated at 200 basis points.
  • Management warned that operational improvements in North America will not be linear, suggesting continued execution challenges.
  • Rising oil costs and tariffs are expected to peak in the back half, specifically highlighting Q4 risk for gross margin outlooks.
Full Analysis
Colgate-Palmolive (CL) faces a critical valuation test ahead of its third-quarter earnings report on October 30, having surged 21.87% year-to-date despite underlying weakness in its core North American market. The stock currently trades at approximately 24x forward 2026 EPS, a demanding multiple for a company guiding only 1% to 4% organic growth. This rally has outpaced the business fundamentals, which show four consecutive quarters of declining net sales in North America driven by volume contraction and retailer inventory cuts. The article highlights significant headwinds including rising oil prices, which have climbed to $107.89 per barrel—well above management's $90 reference price—threatening back-half gross margins. While the company recently beat EPS estimates for six straight quarters with a 4.9% revenue increase, this was driven by pricing power rather than volume growth. Management warns that the second half will be more volume-driven but faces challenges from private label competition and a lack of expected foreign exchange benefits in Latin America. Analyst sentiment has turned cautious, evidenced by three downward revisions to FY2026 EPS consensus estimates over the past 30 days with zero upward revisions. Investors are scrutinizing whether Colgate can prove sequential improvement in its U.S. market and maintain margins against higher input costs. The stock's status as a 'safe haven' based on its long history of dividend increases and global toothpaste market share is being weighed against the risk that the current premium may not be justified if North American contraction continues. The upcoming earnings report will be pivotal in determining if the recent rally is sustainable or if it exposes how much of the stock's value rests on reputation rather than immediate financial performance. Management has indicated that cost pressures and tariffs will peak in the back half, but specifically flagged Q4 risk regarding oil prices. If costs rise while North America continues to contract, the earnings report could reveal that a significant portion of the rally is priced in without corresponding operational improvements.